Lastacaft

Medical Editor: John P. Cunha, DO, FACOEP Last updated on RxList:1/24/2022

Drug Summary

What Is Lastacaft?

Lastacaft (alcaftadine) Ophthalmic Solution is an antihistamine used to prevent itching in the eyes caused by allergies.

What Are Side Effects of Lastacaft?

Common side effects of Lastacaft include:

  • mild and temporary burning/stinging/irritation of the eyes when you apply Lastacaft,
  • eye redness or itching,
  • runny orstuffy nose,
  • sore throat,
  • flu symptoms, or
  • headache.

A very serious allergic reaction to Lastacaft is rare. Get medical help right away if you notice any symptoms of a serious allergic reaction, including: rash, itching or swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing.

Dosage for Lastacaft

The dose of Lastacaft is one drop instilled in each eye once daily.

What Drugs, Substances, or Supplements Interact with Lastacaft?

Lastacaft may interact with other drugs. Tell your doctor all medications and supplements you use.

Lastacaft During Pregnancy and Breastfeeding

During pregnancy, Lastacaft should be used only if prescribed. It is unknown if this drug passes into breast milk. Consult your doctor before breastfeeding.

Additional Information

Our Lastacaft (alcaftadine) Ophthalmic Solution Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

Drug Description

DESCRIPTION

LASTACAFT® is a sterile, topically administered H1 receptorantagonist包含alcaftadine为ophthalmicuse.

Alcaftadine is a white to yellow powder with an empirical formula of C19H21N3O and a molecular weight of 307.39.

Contains

Active:alcaftadine 0.25% (2.5 mg/mL)

Inactives:benzalkonium chloride 0.005% as a preservative; edetate disodium; sodium phosphate, monobasic; purified water; sodium chloride; sodium hydroxide and/or hydrochloric acid (to adjust pH)

Chemical Name:6,11-dihydro-11-(1-methyl-4-piperidinylidene)-5H-imidazo[2,1-b] [3] benzazepine-3-carboxaldehyde

Structural Formula

LASTACAFT® (alcaftadine) Structural Formula Illustration

The drug product has a pH of approximately 7 and an osmolality of approximately 290 mOsm/kg.

Indications & Dosage

INDICATIONS

Purpose

Antihistamine

Use

Temporarily relieves itchy eyes due topollen,ragweed, grass, animal hair anddander

DOSAGE AND ADMINISTRATION

Directions

adults and children 2 years of age and older:

  • put 1 drop in the affected eye(s) once daily
  • if using other ophthalmic products while using this product, wait at least 5 minutes between each
    product
  • replace cap after each use

children under 2 years of age: consult a doctor

HOW SUPPLIED

Other information

  • only for use in the eye
  • store at 15°-25°C (59°-77°F)

Inactive Ingredients

benzalkonium chloride 0.005%, edetate disodium, monobasic sodium phosphate, purified water, sodium chloride, sodium hydroxide and/or hydrochloric acid

Questions or comments?

1.800.678.1605

Distributed by: Allergan USA, Inc. Madison, NJ 07940. Revised: Dec 2021

Side Effects & Drug Interactions

SIDE EFFECTS

No Information Provided

DRUG INTERACTIONS

No Information Provided

Warnings & Precautions

警告

For external use only

PRECAUTIONS

Do not use

  • if solution changes color or becomes cloudy
  • if you are sensitive to any ingredient in this product
  • to treat contactlensrelated irritation

When using this product

  • do not touch tip of container to any surface to avoid contamination
  • remove contact lenses before use
  • wait at least 10 minutes before reinserting contact
  • do not wear a contact lens if your eye is red

Stop use and ask a doctor if you experience any of the following:

  • eye pain
  • changes in vision
  • increased redness of the eye
  • itching that worsens or lasts for more than 72 hours

Keep out of reach of children.

If swallowed, get medical help or contact a Poison Control Center right away

Overdose & Contraindications

OVERDOSE

No information provided.

CONTRAINDICATIONS

LASTACAFT® is contraindicated in patients with hypersensitivity to any component in the product.

Clinical Pharmacology

CLINICAL PHARMACOLOGY

No Information Provided

Medication Guide

PATIENT INFORMATION

No information provided. Please refer to the警告AND PRECAUTIONSsection.

FDA Logo

Report Problems to the Food and Drug Administration

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit theFDA MedWatchwebsite or call 1-800-FDA-1088.

Health SolutionsFrom Our Sponsors